1-19 of 19
Gary E. Gallick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma

Koji Matsuo, Masato Nishimura, Justin N. Bottsford-Miller, Jie Huang, Kakajan Komurov, Guillermo N. Armaiz-Pena, Mian M.K. Shahzad, Rebecca L. Stone, Ju Won Roh, Angela M. Sanguino, Chunhua Lu, Dwight D. Im, Neil B. Rosenshien, Atsuko Sakakibara, Tadayoshi Nagano, Masato Yamasaki, Takayuki Enomoto, Tadashi Kimura, Prahlad T. Ram, Kathleen M. Schmeler, Gary E. Gallick, Kwong K. Wong, Michael Frumovitz, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4450.
https://doi.org/10.1158/1078-0432.CCR-21-2116
Published: 01 August 2021
View article titled, Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma
Open the PDF for Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma in another window
Journal Articles

Editor's Note: Functional Roles of Src and Fgr in Ovarian Carcinoma

Hye-Sun Kim, Hee Dong Han, Guillermo N. Armaiz-Pena, Rebecca L. Stone, Eun Ji Nam, Jeong-Won Lee, Mian M.K. Shahzad, Alpa M. Nick, Sun Joo Lee, Ju-Won Roh, Masato Nishimura, Lingegowda S. Mangala, Justin Bottsford-Miller, Gary E. Gallick, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4452.
https://doi.org/10.1158/1078-0432.CCR-21-2118
Published: 01 August 2021
View article titled, Editor's Note: Functional Roles of <em>Src</em> and <em>Fgr</em> in Ovarian Carcinoma
Open the PDF for Editor's Note: Functional Roles of <em>Src</em> and <em>Fgr</em> in Ovarian Carcinoma in another window
Journal Articles

Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment

Ioulia Vardaki, Paul Corn, Emanuela Gentile, Jian H. Song, Namrata Madan, Anh Hoang, Nila Parikh, Leah Guerra, Yu-Chen Lee, Song-Chang Lin, Guoyu Yu, Elmer Santos, Marites P. Melancon, Patricia Troncoso, Nora Navone, Gary E. Gallick, Eleni Efstathiou, Sumit K. Subudhi, Sue-Hwa Lin, Christopher J. Logothetis, Theocharis Panaretakis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3253–3264.
https://doi.org/10.1158/1078-0432.CCR-20-4790
Published: 01 June 2021
View article titled, Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
Open the PDF for Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment in another window
Includes: Supplementary data
Journal Articles

A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer

Paul G. Corn, Miao Zhang, Graciela M. Nogueras-Gonzalez, Lianchun Xiao, Amado J. Zurita, Sumit K. Subudhi, Shi-Ming Tu, Ana M. Aparicio, Cristian Coarfa, Kimal Rajapakshe, Shixia Huang, Nora M. Navone, Sue-Hwa Lin, Guocan Wang, Sumankalai Ramachandran, Mark A. Titus, Theocharis Panaretakis, Gary E. Gallick, Eleni Efstathiou, Patricia Troncoso, Christopher Logothetis
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 990–999.
https://doi.org/10.1158/1078-0432.CCR-19-2389
Published: 02 March 2020
View article titled, A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer
Open the PDF for A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER

Yunfei Wen, Alpa M Nick, G Lopez-Berestein, Gary E Gallick, Robert L Coleman Robert, Mien-Chie Hung, Anil K Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): AP21.
https://doi.org/10.1158/1557-3265.OVCASYMP18-AP21
Published: 15 November 2019
View article titled, Abstract AP21: A NOVEL TARGET FOR OVERCOMING ADAPTIVE RESISTANCE TO ANTI-ANGIOGENIC THERAPY IN OVARIAN CANCER
Journal Articles

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer

Christine M. Parseghian, Nila U. Parikh, Ji Yuan Wu, Zhi-Qin Jiang, Laura Henderson, Feng Tian, Brice Pastor, Marc Ychou, Kanwal Raghav, Arvind Dasari, David R. Fogelman, Anastasia D. Katsiampoura, David G. Menter, Robert A. Wolff, Cathy Eng, Michael J. Overman, Alain R. Thierry, Gary E. Gallick, Scott Kopetz
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4146–4154.
https://doi.org/10.1158/1078-0432.CCR-16-3138
Published: 01 August 2017
View article titled, Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer
Open the PDF for Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer

Andreas Varkaris, Paul G. Corn, Nila U. Parikh, Eleni Efstathiou, Jian H. Song, Yu-Chen Lee, Ana Aparicio, Anh G. Hoang, Sanchaika Gaur, Lynnelle Thorpe, Sankar N. Maity, Menashe Bar Eli, Bogdan A. Czerniak, Yiping Shao, Mian Alauddin, Sue-Hwa Lin, Christopher J. Logothetis, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 107–121.
https://doi.org/10.1158/1078-0432.CCR-15-0235
Published: 03 January 2016
View article titled, Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer
Open the PDF for Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

Tao Liu, Wei Hu, Heather J. Dalton, Hyun Jin Choi, Jie Huang, Yu Kang, Sunila Pradeep, Takahito Miyake, Jian H. Song, Yunfei Wen, Chunhua Lu, Chad V. Pecot, Justin Bottsford-Miller, Behrouz Zand, Nicholas B. Jennings, Cristina Ivan, Gary E. Gallick, Keith A. Baggerly, David G. Hangauer, Robert L. Coleman, Michael Frumovitz, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6532–6543.
https://doi.org/10.1158/1078-0432.CCR-13-1305
Published: 01 December 2013
View article titled, Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
Open the PDF for Targeting Src and Tubulin in Mucinous Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Muling Mao, Feng Tian, John M. Mariadason, Chun C. Tsao, Robert Lemos, Jr, Farshid Dayyani, Y.N. Vashisht Gopal, Zhi-Qin Jiang, Ignacio I. Wistuba, Xi M. Tang, William G. Bornman, Gideon Bollag, Gordon B. Mills, Garth Powis, Jayesh Desai, Gary E. Gallick, Michael A. Davies, Scott Kopetz
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (3): 657–667.
https://doi.org/10.1158/1078-0432.CCR-11-1446
Published: 31 January 2013
View article titled, Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
Open the PDF for Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents in another window
Includes: Supplementary data
Journal Articles

Targeting Src in Mucinous Ovarian Carcinoma

Koji Matsuo, Masato Nishimura, Justin N. Bottsford-Miller, Jie Huang, Kakajan Komurov, Guillermo N. Armaiz-Pena, Mian M.K. Shahzad, Rebecca L. Stone, Ju Won Roh, Angela M. Sanguino, Chunhua Lu, Dwight D. Im, Neil B. Rosenshien, Atsuko Sakakibara, Tadayoshi Nagano, Masato Yamasaki, Takayuki Enomoto, Tadashi Kimura, Prahlad T. Ram, Kathleen M. Schmeler, Gary E. Gallick, Kwong K. Wong, Michael Frumovitz, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5367–5378.
https://doi.org/10.1158/1078-0432.CCR-10-3176
Published: 14 August 2011
View article titled, Targeting Src in Mucinous Ovarian Carcinoma
Open the PDF for Targeting Src in Mucinous Ovarian Carcinoma in another window
Journal Articles

Functional Roles of Src and Fgr in Ovarian Carcinoma

Hye-Sun Kim, Hee Dong Han, Guillermo N. Armaiz-Pena, Rebecca L. Stone, Eun Ji Nam, Jeong-Won Lee, Mian M. K. Shahzad, Alpa M. Nick, Sun Joo Lee, Ju-Won Roh, Masato Nishimura, Lingegowda S. Mangala, Justin Bottsford-Miller, Gary E. Gallick, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1713–1721.
https://doi.org/10.1158/1078-0432.CCR-10-2081
Published: 31 March 2011
View article titled, Functional Roles of <em>Src</em> and <em>Fgr</em> in Ovarian Carcinoma
Open the PDF for Functional Roles of <em>Src</em> and <em>Fgr</em> in Ovarian Carcinoma in another window
Includes: Supplementary data
Journal Articles

Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players

Michael P. Kim, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1284–1285.
https://doi.org/10.1158/1078-0432.CCR-07-2247
Published: 03 March 2008
View article titled, Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Open the PDF for Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players in another window
Journal Articles

Src Continues Aging: Current and Future Clinical Directions

Scott Kopetz, Ami N. Shah, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7232–7236.
https://doi.org/10.1158/1078-0432.CCR-07-1902
Published: 19 December 2007
View article titled, Src Continues Aging: Current and Future Clinical Directions
Open the PDF for Src Continues Aging: Current and Future Clinical Directions in another window
Includes: Supplementary data
Journal Articles

Treatment for Advanced Tumors: Src Reclaims Center Stage

Justin M. Summy, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1398–1401.
https://doi.org/10.1158/1078-0432.CCR-05-2692
Published: 06 March 2006
View article titled, Treatment for Advanced Tumors: Src Reclaims Center Stage
Open the PDF for Treatment for Advanced Tumors: Src Reclaims Center Stage in another window
Journal Articles

Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor

E. Ramsay Camp, Justin Summy, Todd W. Bauer, Wenbiao Liu, Gary E. Gallick, Lee M. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 397–405.
https://doi.org/10.1158/1078-0432.397.11.1
Published: 21 January 2005
View article titled, Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
Open the PDF for Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor in another window
Journal Articles

Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness

Douglas D. Boyd, Heng Wang, Hector Avila, Nila U. Parikh, Horst Kessler, Victor Magdolen, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1545–1555.
https://doi.org/10.1158/1078-0432.CCR-1565-02
Published: 20 February 2004
View article titled, Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes <em>in Vitro</em> Colon Cancer Invasiveness
Open the PDF for Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes <em>in Vitro</em> Colon Cancer Invasiveness in another window
Journal Articles

Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model

Sun Jin Kim, Marjorie Johnson, Kristen Koterba, Matthew H. Herynk, Hisanori Uehara, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5161–5170.
Published: 12 November 2003
View article titled, Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model
Open the PDF for Reduced c-Met Expression by an Adenovirus Expressing a c-Met Ribozyme Inhibits Tumorigenic Growth and Lymph Node Metastases of PC3-LN4 Prostate Tumor Cells in an Orthotopic Nude Mouse Model in another window
Journal Articles

Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells

Michael A. Davies, Sun J. Kim, Nila U. Parikh, Zhongyun Dong, Corazon D. Bucana, Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1904–1914.
Published: 01 June 2002
View article titled, Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells
Open the PDF for Adenoviral-mediated Expression of MMAC/PTEN Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells in another window
Journal Articles

Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model

Jon R. Wiener, Kayo Nakano, Russell P. Kruzelock, Corazon D. Bucana, Robert C. Bast, Jr., Gary E. Gallick
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2164–2170.
Published: 01 August 1999
View article titled, Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model
Open the PDF for Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model in another window